GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Xtacy Therapeutics Corp (FRA:TT5) » Definitions » FCF Yield %

Xtacy Therapeutics (FRA:TT5) FCF Yield % : -4.97 (As of May. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Xtacy Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Xtacy Therapeutics's Trailing 12-Month Free Cash Flow is €-0.06 Mil, and Market Cap is €1.11 Mil. Therefore, Xtacy Therapeutics's FCF Yield % for today is -4.97%.

The historical rank and industry rank for Xtacy Therapeutics's FCF Yield % or its related term are showing as below:

FRA:TT5' s FCF Yield % Range Over the Past 10 Years
Min: -71.8   Med: -6.42   Max: -0.49
Current: -4.97


During the past 13 years, the highest FCF Yield % of Xtacy Therapeutics was -0.49%. The lowest was -71.80%. And the median was -6.42%.

FRA:TT5's FCF Yield % is ranked worse than
59.59% of 537 companies
in the Credit Services industry
Industry Median: -0.98 vs FRA:TT5: -4.97

Xtacy Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Xtacy Therapeutics FCF Yield % Historical Data

The historical data trend for Xtacy Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtacy Therapeutics FCF Yield % Chart

Xtacy Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.90 -2.64 -1.66 -5.18 -2.83

Xtacy Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 -6.83 22.13 -30.33 -

Competitive Comparison of Xtacy Therapeutics's FCF Yield %

For the Credit Services subindustry, Xtacy Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtacy Therapeutics's FCF Yield % Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Xtacy Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Xtacy Therapeutics's FCF Yield % falls into.



Xtacy Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Xtacy Therapeutics's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.056 / 1.978443
=-2.83%

Xtacy Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 0.6151875
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xtacy Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Xtacy Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Xtacy Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtacy Therapeutics (FRA:TT5) Business Description

Traded in Other Exchanges
Address
1100 - 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
Xtacy Therapeutics Corp Formerly Global Wellness Strategies Inc is a debt financing company. The company provides a debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It is focusing on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.

Xtacy Therapeutics (FRA:TT5) Headlines

No Headlines